JPMorgan Chase & Co. (NYSE: JPM) – For an in-depth report on JPMorgan Chase & Co. follow: www.BullTrends.com/stockquote/JPM
Shares of JPMorgan closed down 3.66% on about 47.2 million shares traded. The stock was one of the biggest decliners on the NYSE. The company’s first-quarter earnings fell 20 percent. The bank reported net income of $4.9 billion for the first quarter; this was down from $6.1 billion in the same period a year earlier.
Biogen Idec Inc. (NASDAQ: BIIB) - For an in-depth report on Biogen Idec Inc. follow: www.BullTrends.com/stockquote/BIIB
Shares of Biogen Idec Inc. closed down 4.65% on about 2.7 million shares traded. The stock was one of the biggest decliners on the NASDAQ. The company and its partner Swedish Orphan Biovitrum announced positive results for Eloctate, their experimental hemophilia A drug. In a late-stage study, the blood-clotting drug "was generally well-tolerated, and no inhibitors (interfering antibodies) were detected," the companies said in a statement.
Canadian Solar Inc. (NASDAQ: CSIQ) - For an in-depth report on Canadian Solar Inc. follow: www.BullTrends.com/stockquote/CSIQ
Shares of Canadian Solar Inc. closed down 6.33% on about 7.2 million shares traded. The stock was one of the biggest decliners on the NASDAQ. Earlier this month the company received a $46 million loan from Manulife Financial Corp. for its Mighty project in Ontario. The 10-megawatt solar farm is expected to begin producing power in the second quarter, Guelph, Ontario-based Canadian Solar said today in a statement.
Herbalife Ltd. (NYSE: HLF) – For an in-depth report on Herbalife Ltd. follow: www.BullTrends.com/stockquote/HLF
Herbalife closed down nearly 14% this past Friday after it was revealed that the Justice Department and the FBI have opened an investigation of Los Angeles nutritional products company. Critics have been saying the company is operating an illegal pyramid scheme.
Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.